Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.
Regeneus
Follow
Get notifications in MyBN when activity occurs.
Company Activity
NEWS: Tagged in Regeneus trebles on back of merger deal | 05 Apr 2024 | |
NEW ROLE: John Chiplin, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Graham Vesey, Chief Scientific Officer, Executive Director | 03 Nov 2020 | |
NEW ROLE: Alan Dunton, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Leo Lee, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Sandra McIntosh, Company Secretary | 03 Nov 2020 | |
NEW ROLE: Karolis Rosickas, Chief Executive Officer | 03 Nov 2020 | |
NEW ROLE: Barry Sechos, Non-Executive Director, Chair since 2019 | 03 Nov 2020 |